<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<style type="text/css" style="display:none;"> P {margin-top:0;margin-bottom:0;} </style>
<style type="text/css">.style1 {font-family: "Times New Roman";}</style></head><body dir="ltr">
<div class="elementToProof"><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);">Hi there,</span></div>
<div><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);"><br>
</span></div>
<div><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);">You are invited to a Zoom webinar.</span></div>
<div><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);">When: Feb 28, 2024 13:00 Johannesburg</span></div>
<div><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);">Topic: BPAL implementation: Progress, challenges, and scaling up</span></div>
<div class="elementToProof"><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);">Register in advance for this webinar:</span></div>
<div class="elementToProof"><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);"><br>
</span></div>
<div class="elementToProof"><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);"><a href="https://zoom.us/webinar/register/WN_d-BIczinQH6VOkEJoOKEFw" id="LPlnk">https://zoom.us/webinar/register/WN_d-BIczinQH6VOkEJoOKEFw</a> </span></div>
<div class="_Entity _EType_OWALinkPreview _EId_OWALinkPreview _EReadonly_1">
<div id="LPBorder_GTaHR0cHM6Ly96b29tLnVzL3dlYmluYXIvcmVnaXN0ZXIvV05fZC1CSWN6aW5RSDZWT2tFSm9PS0VGdw.." class="LPBorder808521" style="width: 100%; margin-top: 16px; margin-bottom: 16px; position: relative; max-width: 800px; min-width: 424px;">
<table id="LPContainer808521" role="presentation" style="padding: 12px 36px 12px 12px; width: 100%; border-width: 1px; border-style: solid; border-color: rgb(200, 200, 200); border-radius: 2px;">
<tbody>
<tr valign="top" style="border-spacing: 0px;">
<td>
<div id="LPImageContainer808521" style="position: relative; margin-right: 12px; height: 126px; overflow: hidden; width: 240px;">
<a target="_blank" id="LPImageAnchor808521" href="https://zoom.us/webinar/register/WN_d-BIczinQH6VOkEJoOKEFw"><img id="LPThumbnailImageId808521" alt="" height="126" width="240" style="display: block;" src="https://st3.zoom.us/static/6.3.19658/image/thumb.png"></a></div>
</td>
<td style="width: 100%;">
<div id="LPTitle808521" style="font-size: 21px; font-weight: 300; margin-right: 8px; font-family: wf_segoe-ui_light, "Segoe UI Light", "Segoe WP Light", "Segoe UI", "Segoe WP", Tahoma, Arial, sans-serif; margin-bottom: 12px;">
<a target="_blank" id="LPUrlAnchor808521" href="https://zoom.us/webinar/register/WN_d-BIczinQH6VOkEJoOKEFw" style="text-decoration: none; color: var(--themePrimary);">Welcome! You are invited to join a webinar: BPAL implementation: Progress, challenges, and
scaling up. After registering, you will receive a confirmation email about joining the webinar.</a></div>
<div id="LPDescription808521" style="font-size: 14px; max-height: 100px; color: rgb(102, 102, 102); font-family: wf_segoe-ui_normal, "Segoe UI", "Segoe WP", Tahoma, Arial, sans-serif; margin-bottom: 12px; margin-right: 8px; overflow: hidden;">
Main objectives: Background of BPAL-L Describe the background of shortened DR-TB regimens and why the BPAL-L regimen was adopted. Progress Assessment Evaluate the status of BPAL (Bedaquiline, Pretomanid, Linezolid) implementation efforts, including the adoption
rates, accessibility, and utilization of these drugs in the treatment of TB. Identification of Challenges Identify and discuss the challenges encountered in the implementation process, such as regulatory hurdles, supply chain issues, healthcare infrastructure
limitations, and patient access barriers. Strategies for Scale-Up Explore effective strategies for scaling up BPAL implementation, including capacity building for healthcare workers, advocacy for policy changes, strengthening of healthcare systems, and collaboration
with stakeholders at local, national, and international levels.</div>
<div id="LPMetadata808521" style="font-size: 14px; font-weight: 400; color: rgb(166, 166, 166); font-family: wf_segoe-ui_normal, "Segoe UI", "Segoe WP", Tahoma, Arial, sans-serif;">
zoom.us</div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
<div style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);">
<br>
</div>
<div><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);"><br>
</span></div>
<div><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);"><br>
</span></div>
<div><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);">After registering, you will receive a confirmation email containing information about joining the webinar.</span></div>
<div><span style="font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);"><br>
<br>
</span></div>
<br><br><p style="font-family: Verdana; font-size:10pt; color:#666666;"><b>Disclaimer</b></p><p style="font-family: Verdana; font-size:8pt; color:#666666;">The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying, distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful.<br><br>This email has been scanned for viruses and malware, and may have been automatically archived by <b>Mimecast Ltd</b>, an innovator in Software as a Service (SaaS) for business. Providing a <b>safer</b> and <b>more useful</b> place for your human generated data. Specializing in; Security, archiving and compliance. To find out more <a href="http://www.mimecast.com/products/" target="_blank">Click Here</a>.</p></body></html>